Asker Healthcare Group AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	15,025	13,453	11,718	9,354
Revenue Growth (YoY)	11.68%	14.81%	25.27%	-
Cost of Revenue	9,147	8,934	7,936	6,741
Gross Profit	5,878	4,519	3,782	2,613
Selling, General & Admin	4,851	3,886	2,674	1,778
Other Operating Expenses	-15	-7	-	-
Operating Expenses	4,836	3,879	3,069	2,008
Operating Income	1,042	640	713	605
Interest Expense	-302	-264	-186	-23
Interest & Investment Income	9	3	1	1
Currency Exchange Gain (Loss)	-1	24	93	-27
Other Non Operating Income (Expenses)	-73	-34	-60	-12
EBT Excluding Unusual Items	675	369	561	544
Gain (Loss) on Sale of Assets	32	-	-	-
Other Unusual Items	-149	-61	-	-
Pretax Income	558	308	561	544
Income Tax Expense	183	103	127	74
Earnings From Continuing Operations	375	205	434	470
Minority Interest in Earnings	-15	-2	-4	-3
Net Income	360	203	430	467
Net Income to Common	360	203	430	467
Net Income Growth	77.34%	-52.79%	-7.92%	-
Shares Outstanding (Basic)	263	262	258	236
Shares Outstanding (Diluted)	263	262	258	236
Shares Change (YoY)	0.40%	1.55%	9.55%	-
EPS (Basic)	1.37	0.77	1.67	1.98
EPS (Diluted)	1.37	0.77	1.67	1.98
EPS Growth	76.63%	-53.51%	-15.95%	-
Free Cash Flow	879	901	853	258
Free Cash Flow Per Share	3.34	3.44	3.30	1.09
Gross Margin	39.12%	33.59%	32.27%	27.93%
Operating Margin	6.93%	4.76%	6.08%	6.47%
Profit Margin	2.40%	1.51%	3.67%	4.99%
Free Cash Flow Margin	5.85%	6.70%	7.28%	2.76%
EBITDA	1,351	933	896	670
EBITDA Margin	8.99%	6.93%	7.65%	7.16%
D&A For EBITDA	309	293	183	65
EBIT	1,042	640	713	605
EBIT Margin	6.93%	4.76%	6.08%	6.47%
Effective Tax Rate	32.80%	33.44%	22.64%	13.60%
Revenue as Reported	-	-	11,751	9,378

Source: S&P Global Market Intelligence. Standard template. Financial Sources.